These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 17904294)

  • 1. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T
    Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging treatments for chronic lymphocytic leukaemia.
    Robak T; Jamroziak K; Robak P
    Drugs; 2009; 69(17):2415-49. PubMed ID: 19911856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L
    Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic lymphocytic leukemia.
    Han T; Rai KR
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
    Robak T; Kasznicki M
    Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New agents in chronic lymphocytic leukemia.
    Robak T
    Curr Treat Options Oncol; 2006 May; 7(3):200-12. PubMed ID: 16615876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of advanced chronic lymphocytic leukemia.
    Cao TM; Coutre SE
    Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia.
    Keating MJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic lymphatic leukemia].
    Adam Z; Vorlícek J; Hejlová N
    Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the treatment of B-cell chronic lymphocytic leukemia.
    Cheson BD
    Oncology (Williston Park); 1990 Sep; 4(9):71-8, 83-4; disc. 84, 87-8, 90 pass. PubMed ID: 2145022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome.
    Montillo M; Schinkoethe T; Elter T
    Cancer Invest; 2005; 23(6):488-96. PubMed ID: 16203656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives.
    García-Escobar I; Sepúlveda J; Castellano D; Cortés-Funes H
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):100-13. PubMed ID: 21146422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
    Kay NE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.